These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 13680265)

  • 41. Laboratory screening of hemoglobinopathies.
    Chan MS; Schneider NJ
    Health Lab Sci; 1975 Apr; 12(2):91-9. PubMed ID: 1052518
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Comparison of the accuracy of dichlorophenolindophenol (DCIP), modified DCIP, and hemoglobin E tests to screen for the HbE trait in pregnant women.
    Wanapirak C; Sirichotiyakul S; Luewan S; Srisupundit K; Tongsong T
    Int J Gynaecol Obstet; 2009 Oct; 107(1):59-60. PubMed ID: 19477441
    [No Abstract]   [Full Text] [Related]  

  • 43. Pregnant women identified as hemoglobinopathy carriers by prenatal screening want genetic counseling and use information provided.
    Rowley PT; Loader S; Walden M
    Birth Defects Orig Artic Ser; 1988; 23(5B):449-54. PubMed ID: 3390574
    [No Abstract]   [Full Text] [Related]  

  • 44. Spectrum of anemia in pregnant Indian women and importance of antenatal screening.
    Sinha M; Panigrahi I; Shukla J; Khanna A; Saxena R
    Indian J Pathol Microbiol; 2006 Jul; 49(3):373-5. PubMed ID: 17001888
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Reagent strip testing for antenatal screening and first meaningful of asymptomatic bacteriuria in pregnant women.
    Kovavisarach E; Vichaipruck M; Kanjanahareutai S
    J Med Assoc Thai; 2008 Dec; 91(12):1786-90. PubMed ID: 19133509
    [TBL] [Abstract][Full Text] [Related]  

  • 46. False positive rates of thalassemia screening in rural clinical setting: 10-year experience in Thailand.
    Jopang Y; Thinkhamrop B; Puangpruk R; Netnee P
    Southeast Asian J Trop Med Public Health; 2009 May; 40(3):576-80. PubMed ID: 19842446
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Antenatal syphilis screening in sub-Saharan Africa: lessons learned from Tanzania.
    Watson-Jones D; Oliff M; Terris-Prestholt F; Changalucha J; Gumodoka B; Mayaud P; Semakafu AM; Kumaranayake L; Gavyole A; Mabey D; Hayes R
    Trop Med Int Health; 2005 Sep; 10(9):934-43. PubMed ID: 16135202
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Cost-effectiveness estimates for antenatal HIV testing in the Netherlands.
    Rozenbaum MH; Verweel G; Folkerts DK; Dronkers F; van den Hoek JA; Hartwig NG; de Groot R; Postma MJ
    Int J STD AIDS; 2008 Oct; 19(10):668-75. PubMed ID: 18824618
    [TBL] [Abstract][Full Text] [Related]  

  • 49. An analysis of relative costs and potential benefits of different policies for antenatal screening for beta thalassaemia trait and variant haemoglobins.
    Phelan L; Bain BJ; Roper D; Jury C; Bain K
    J Clin Pathol; 1999 Sep; 52(9):697-700. PubMed ID: 10655995
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [The standard "Anemia in first line obstetric practice" from the Royal Dutch Organization of Obstetricians (KNOV): risk for not acknowledging iron deficiency and hemoglobin abnormalities].
    Daemers DO; Amelink-Verburg MP; Rijnders ME
    Ned Tijdschr Geneeskd; 2002 May; 146(21):1011-3; author reply 1012-3. PubMed ID: 12058622
    [No Abstract]   [Full Text] [Related]  

  • 51. [Present status and problems of mass screening--from the viewpoint of public health].
    Miyake K
    Hokkaido Igaku Zasshi; 1986 Jul; 61(4):515-9. PubMed ID: 3093347
    [No Abstract]   [Full Text] [Related]  

  • 52. [Screening. What documentation should be required?].
    Olsen J
    Ugeskr Laeger; 2002 Jan; 164(2):148-52. PubMed ID: 11831074
    [No Abstract]   [Full Text] [Related]  

  • 53. Serum vitamin A and E in pregnant women with hemoglobinopathies.
    Phuapradit W; Panburana P; Jaovisidha A; Chanrachakul B; Bunyaratvej A; Puchaiwatananon O
    J Obstet Gynaecol Res; 1999 Jun; 25(3):173-6. PubMed ID: 10467789
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Hemoglobin E disease in pregnancy.
    Das CK
    Int J Gynaecol Obstet; 1984 Oct; 22(5):389-91. PubMed ID: 6151925
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Blood donor rejection rate: HemoCue hemoglobin analyzer vs. microhematocrit.
    Russell BL; Martin SM
    Clin Lab Sci; 1997; 10(6):321-4. PubMed ID: 10175331
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Hemoglobin screening: response of a Brazilian community to optional programs].
    Ramalho AS; de Paiva e Silva RB; Teixeira RC; Compri MB
    Cad Saude Publica; 1999; 15(3):591-5. PubMed ID: 10502155
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Screening for anemia in pregnancy with copper sulfate densitometry.
    Pistorius LR; Funk M; Pattinson RC; Howarth GR
    Int J Gynaecol Obstet; 1996 Jan; 52(1):33-6. PubMed ID: 8620986
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Automated computer result reporting for haemoglobinopathy screening.
    Daniel Y; Witchlow B; Almeida A
    Clin Lab Haematol; 2004 Feb; 26(1):21-4. PubMed ID: 14738433
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Prevalence of hemoglobinopathies in Nefza: study of 1303 patients].
    Znaidi R; Hafsia R; M'Rad A; Belhadj A; Kastally R; Hafsia A
    Tunis Med; 1992; 70(8-9):400-4. PubMed ID: 1485391
    [No Abstract]   [Full Text] [Related]  

  • 60. Hemoglobinopathy screening during early pregnancy.
    Anyane-Yeboa K
    Pediatrics; 1989 May; 83(5 Pt 2):881-3. PubMed ID: 2717320
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.